Upgrades/Downgrades
Updated: 19-Aug-25 16:30 ET
| Upgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Thomson Reuters | TRI | CIBC | Neutral » Sector Outperform | ||
| Target Hospitality | TH | Stifel | Hold » Buy | $11 | |
| Prologis | PLD | Mizuho | Neutral » Outperform | $118 | |
| Palo Alto Networks | PANW | BofA Securities | Neutral » Buy | $215 | |
| Live Oak Bancshares | LOB | Keefe Bruyette | Mkt Perform » Outperform | $43 | |
| Global Net Lease | GNL | KeyBanc Capital Markets | Sector Weight » Overweight | $9 | |
| Gilead Sciences | GILD | Daiwa Securities | Neutral » Outperform | $128 | |
| Crown Castle | CCI | BMO Capital Markets | Market Perform » Outperform | $120 | |
| Caterpillar | CAT | Evercore ISI | In-line » Outperform | $476 | |
| Broadstone Net Lease | BNL | KeyBanc Capital Markets | Sector Weight » Overweight | $20 | |
| Aveanna | AVAH | Barclays | Equal Weight » Overweight | $9.50 | |
| Aveanna | AVAH | UBS | Sell » Neutral | $8 | |
|
|
|||||
| Downgrades | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Prairie Operating Co. | PROP | Piper Sandler | Overweight » Neutral | $3 | |
| Li Auto | LI | Bernstein | Outperform » Mkt Perform | $26 | |
| FEMSA | FMX | Morgan Stanley | Overweight » Equal-Weight | $97 | |
| EPR Properties | EPR | KeyBanc Capital Markets | Overweight » Sector Weight | ||
|
|
|||||
| Coverage Initiated | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Unusual Machines | UMAC | Needham | Buy | $15 | |
| AeroVironment | AVAV | Needham | Buy | $300 | |
| UroGen Pharma | URGN | Piper Sandler | Overweight | $36 | |
| Tango Therapeutics | TNGX | Piper Sandler | Overweight | $11 | |
| Thermo Fisher | TMO | William Blair | Outperform | ||
| Summit Therapeutics | SMMT | Piper Sandler | Neutral | $21 | |
| Revolution Medicines | RVMD | Piper Sandler | Overweight | $75 | |
| Rocket Companies | RKT | BTIG Research | Buy | $25 | |
| Ralliant Corporation | RAL | RBC Capital Mkts | Sector Perform | $47 | |
| Ondas Holdings | ONDS | Needham | Buy | $5 | |
| Nuvalent | NUVL | Piper Sandler | Overweight | $112 | |
| loanDepot | LDI | BTIG Research | Neutral | ||
| Janux Therapeutics | JANX | Piper Sandler | Overweight | $42 | |
| Hesai Group | HSAI | UBS | Buy | $35 | |
| First Financial Bancorp | FFBC | Hovde Group | Outperform | $31 | |
| Day One Biopharmaceuticals | DAWN | Piper Sandler | Overweight | $25 | |
| CG Oncology | CGON | Piper Sandler | Overweight | $55 | |
| Bicara Therapeutics | BCAX | Piper Sandler | Overweight | $36 | |
|
|
|||||
| Coverage Resumed | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Valneva SE | VALN | H.C. Wainwright | Buy | $18 | |
| Genfit | GNFT | H.C. Wainwright | Buy | $9 | |
|
|
|||||
| Coverage Reiterated/Price Tgt Changed* | |||||
| Company | Ticker | Brokerage Firm | Ratings Change | Price Target | |
| Palo Alto Networks | PANW | BMO Capital Markets | Outperform | $217 » $225 | |
| Helmerich & Payne | HP | TD Cowen | Hold | $26 » $27 | |
|
|
|||||
| (a) Brokerage firm initiating coverage participated in underwriting the recent IPO. |
| (b) Brokerage firm resumes coverage. |
| (c) Brokerage firm participated in the secondary offering. |
| * This list of reiterations/target changes is not comprehensive. |